MRIGlobal's Containerized Bio Containment System (CBCS) wins R&D Magazine's R&D 100 Award
Kansas City, Mo. – MRIGlobal's state-of-the-art, flight-ready Containerized Biocontainment System (CBCS) has been awarded an R&D100 Award for Innovation by R&D Magazine. Each year R&D Magazine presents the awards to 100 of the most technologically significant and innovative technologies introduced to the marketplace over the past year.
Effectively addressing global public health challenges, such as Ebola, requires the commitment of medical professionals. A major recruitment challenge has been limited access to medical evacuation should health workers become ill and need access to medical treatment. To help solve this challenge, a $5 million dollar private-public partnership grant between Paul G. Allen and the State Department was established for the development and manufacture of the CBCS.
MRIGlobal designed the CBCS as a reusable bio-containment and medical treatment unit to operate on government/civilian cargo aircraft. Able to fully contain highly-contagious pathogens, the extremely durable and safe CBCS units allow for the secure transport of healthcare workers abroad. The CBCS can treat four critically ill patients while maintaining biocontainment and safe flight.
"The CBCS was designed to save lives," said Dean Gray, Ph.D., Director of Special Programs, MRIGlobal. "There's nothing like this in the world right now and it was developed in response to an urgent need. With CBCS, the world is ready for the next big event."
See the video here: https://youtu.be/RI7WcxRSWhA
Winners were presented with their honors at the 54th Annual R&D Awards dinner on November 3.